Sign in
4

Changes in Ownership

Edesa Biotech, Inc. Filed Acc 0001144204-18-014761

Director sold 32,300 shares at an average $0.79 ($25,600)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
MORSE DANIEL E. Director 2018-02-22 Sale −7,800 $0.78 $6,115 28,866 I
MORSE DANIEL E. Director 2018-02-26 Sale −7,000 $0.79 $5,530 21,866 I
MORSE DANIEL E. Director 2018-02-28 Sale −7,000 $0.79 $5,530 14,866 I
MORSE DANIEL E. Director 2018-03-09 Sale −7,000 $0.81 $5,635 7,866 I
MORSE DANIEL E. Director 2018-03-12 Sale −3,500 $0.80 $2,790 4,366 I
Derivatives
MORSE DANIEL E. Director 2018-03-12 Grant or award · Share Option (Right to Buy) +2,500 2,500 D
Open-market sales · 32,300 sh · avg $0.79 · $25,600
Loading xslF345X03/tv488572_4.xml…